The advent of genomic and proteomics technologies and the rapidly evolving understanding of the human genome are energizing a sea change in the medical laboratory. The new paradigm for success is about harnessing these revolutionary advances in science and medicine to develop better, more patient specific tools for diagnosis and prognosis of disease. At the heart and soul of Esoterix is a driving passion to find, develop, and implement these innovative new laboratory tests for better patient care. We believe that the only way to effectively deliver the promise of these emerging technologies is by practicing high science with experts in the field. Our reputation for practicing high science has allowed us to attract a scientific and medical professional staff composed of thought-leaders at the forefront of developing and delivering tomorrow's laboratory technology, today.

Our industry-leading oncology laboratories specialize in cancer diagnosis utilizing the most sophisticated cell analysis tools available today. Multidimensional flow cytometry, quantitative immunohistochemistry, and molecular genetic and cytogenetics analysis capabilities are focused on individual patient diagnostic dilemmas to deliver integrated diagnostic and prognostic information required for effective tumor-specific therapy. Esoterix's endocrinology laboratory pioneered the analysis of steroids for the evaluation of children with endocrine disorders. That tradition of innovation continues today with Esoterix leading the way in the development and launch of groundbreaking new molecular genetic assays for short stature and diabetes, and in the implementation of cutting edge tandem mass spectrometry for the analysis of steroids.

The Esoterix Center for Innovation, our multi-million dollar research and development organization, is sought out by pharmaceutical companies to aid in the discovery and development of new assays for the analysis of the pharmacokinetics and pharmacodynamics of novel, experimental, biological therapies, which are the beginning of the promise of the new personalized medicine. The tests developed in support of these experimental clinical studies will be the diagnostic tests of the future, designed to identify patients for whom the new drugs will be effective, and to monitor the course of therapy.

At Esoterix, our commitment to high science, practiced by industry-leading scientists and physicians, guarantees our customers' access to the latest developments in diagnostic testing. Offering our clients access to new technology, however, is not enough. Along with that comes a responsibility to ensure a complete understanding of the new tests and how the information derived from them should be used for better patient care. The Esoterix commitment to superior customer service ensures our clients will receive the professional consultation required to understand fully how to utilize the latest diagnostic information for better patient care. At Esoterix, we take high science seriously. We practice it, we preach it, we teach it -- because at the other end of a specimen in our laboratory is a sick patient who deserves the best that modern laboratory medicine has to offer.

Gregory T. Stelzer, Ph.D.
Senior Vice President and Chief Scientific Officer